SCHEMBL12284013

SCHEMBL12284013

CC(C)(C)OC(=O)N[C@H]1CCN(c2c(C=O)cccc2OCC(F)(F)F)C1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 1/20 0.47
▸ PIM3 Q86V86 1/20 0.47
▸ PIM2 Q9P1W9 1/20 0.47
▸ SSTR1 P30872 2/20 0.43
▸ SSTR4 P31391 2/20 0.43
▸ SYK P43405 1/20 0.42
▸ ITGB2 P05107 1/20 0.42
▸ ICAM1 P05362 1/20 0.42
▸ ITGAL P20701 1/20 0.42
▸ CKS1B P61024 1/20 0.41
▸ SKP1 P63208 1/20 0.41
▸ SKP2 Q13309 1/20 0.41
▸ SUV39H2 Q9H5I1 8/20 0.41
▸ PDE10A Q9Y233 1/20 0.41
▸ SCN9A Q15858 1/20 0.40
▸ MAP4K4 O95819 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12284337 0.95 MAP4K4 (0.46) PIM1PIM3PIM2SSTR1SSTR4
SCHEMBL12284452 0.90 PIM1 (0.49) PIM1PIM3PIM2SSTR4CKS1B
SCHEMBL12322662 0.87 PIM1 (0.47) PIM1PIM3PIM2CKS1BSKP1
SCHEMBL12284134 0.87 PIM1 (0.52) PIM1PIM3PIM2CKS1BSKP1
SCHEMBL2426572 0.85 PIM2 (0.69) PIM1PIM3PIM2
SCHEMBL12283559 0.84 MAP4K4 (0.48) PIM1PIM3PIM2CKS1BSKP1
SCHEMBL30079320 0.84 PIM1 (0.52) PIM1PIM3PIM2CKS1BSKP1
SCHEMBL12283763 0.83 MAP4K4 (0.46) PIM1PIM3PIM2PDE10AMAP4K4
SCHEMBL13537761 0.83 PIM1 (0.53) PIM1PIM3PIM2CKS1BSKP1
SCHEMBL12283494 0.82 PIM1 (0.46) PIM1PIM3PIM2PDE10AMAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150051185-A1 Chemical Compounds 251 ASTRAZENECA AB (SE) 2015-02-19 — — US disclosed
US-20150051185-A1 Chemical Compounds 251 ASTRAZENECA AB (SE) 2015-02-19 — — US disclosed
US-8901307-B2 Chemical compounds 251 ASTRAZENECA AB (SE) 2014-12-02 — — US disclosed
US-8901307-B2 Chemical compounds 251 ASTRAZENECA AB (SE) 2014-12-02 — — US disclosed
US-20110218182-A1 CHEMICAL COMPOUNDS 251 ASTRAZENECA AB (SE) 2011-09-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110218182-A1 CHEMICAL COMPOUNDS 251 PIM1, PIM3, PIM2 PIM1 1/4885PIM3 2/4885PIM2 3/4885
US-20150051185-A1 Chemical Compounds 251 PIM1, PIM3, PIM2 PIM1 1/4885PIM3 2/4885PIM2 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback